Suzhou Kintor Raises $44 Million for Novel Drug Portfolio
January 12, 2018 at 05:05 AM EST
Suzhou Kintor Pharma raised $44 million in a funding led by Shenzhen Green Pine Capital Partners. Established in 2009, Kintor is an innovative high-tech pharma developing novel products. Since its founding, the company has received over 25 Significant New Drug Creation awards, plus the China Science and Technology Ministry's small and mid-size enterprise innovation funding support along with other awards. More details.... Share this with colleagues: // //